Itron (NASDAQ:ITRI) Earns “Equal Weight” Rating from Stephens

Itron (NASDAQ:ITRIGet Free Report)‘s stock had its “equal weight” rating reissued by stock analysts at Stephens in a report issued on Tuesday,Benzinga reports. They presently have a $130.00 target price on the scientific and technical instruments company’s stock. Stephens’ target price points to a potential upside of 3.22% from the company’s previous close.

Other equities analysts have also issued reports about the company. JPMorgan Chase & Co. upgraded Itron from a “neutral” rating to an “overweight” rating and increased their price objective for the company from $128.00 to $145.00 in a research report on Thursday, July 31st. TD Cowen increased their price target on shares of Itron from $139.00 to $145.00 and gave the company a “buy” rating in a research report on Friday, June 20th. Weiss Ratings reissued a “buy (b)” rating on shares of Itron in a research note on Saturday, September 27th. Johnson Rice downgraded Itron from a “buy” rating to an “accumulate” rating in a research report on Friday, August 1st. Finally, Roth Capital increased their target price on shares of Itron from $130.00 to $150.00 and gave the stock a “buy” rating in a report on Tuesday, July 22nd. Ten analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat, Itron presently has an average rating of “Moderate Buy” and an average price target of $137.10.

Check Out Our Latest Report on ITRI

Itron Price Performance

ITRI stock opened at $125.94 on Tuesday. The firm has a 50 day simple moving average of $123.82 and a two-hundred day simple moving average of $119.44. The stock has a market cap of $5.76 billion, a PE ratio of 21.53, a P/E/G ratio of 0.69 and a beta of 1.48. Itron has a one year low of $90.11 and a one year high of $140.04. The company has a debt-to-equity ratio of 0.48, a current ratio of 2.04 and a quick ratio of 1.75.

Itron (NASDAQ:ITRIGet Free Report) last announced its earnings results on Thursday, July 31st. The scientific and technical instruments company reported $1.62 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.33 by $0.29. Itron had a net margin of 11.05% and a return on equity of 19.69%. The company had revenue of $606.76 million during the quarter, compared to analyst estimates of $610.36 million. During the same period in the previous year, the business earned $1.21 earnings per share. The firm’s quarterly revenue was down .4% compared to the same quarter last year. Itron has set its FY 2025 guidance at 6.000-6.200 EPS. Q3 2025 guidance at 1.450-1.550 EPS. On average, analysts predict that Itron will post 5.33 EPS for the current fiscal year.

Insider Buying and Selling at Itron

In other news, SVP Donald L. Reeves III sold 547 shares of the company’s stock in a transaction on Monday, August 25th. The stock was sold at an average price of $125.31, for a total transaction of $68,544.57. Following the transaction, the senior vice president directly owned 19,604 shares of the company’s stock, valued at $2,456,577.24. This represents a 2.71% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, SVP John F. Marcolini sold 565 shares of the firm’s stock in a transaction dated Monday, August 25th. The shares were sold at an average price of $125.31, for a total transaction of $70,800.15. Following the sale, the senior vice president directly owned 14,396 shares in the company, valued at approximately $1,803,962.76. The trade was a 3.78% decrease in their position. The disclosure for this sale can be found here. Insiders sold 3,037 shares of company stock worth $380,566 in the last 90 days. Insiders own 1.45% of the company’s stock.

Institutional Trading of Itron

Several large investors have recently added to or reduced their stakes in the business. Twin Peaks Wealth Advisors LLC purchased a new stake in Itron during the second quarter valued at approximately $30,000. Bessemer Group Inc. grew its position in shares of Itron by 125.7% during the 2nd quarter. Bessemer Group Inc. now owns 255 shares of the scientific and technical instruments company’s stock valued at $34,000 after acquiring an additional 142 shares during the period. Wayfinding Financial LLC purchased a new stake in shares of Itron in the 1st quarter worth $45,000. Northwestern Mutual Wealth Management Co. raised its holdings in Itron by 343.6% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 346 shares of the scientific and technical instruments company’s stock worth $46,000 after purchasing an additional 268 shares during the period. Finally, EverSource Wealth Advisors LLC lifted its position in Itron by 25.3% during the second quarter. EverSource Wealth Advisors LLC now owns 401 shares of the scientific and technical instruments company’s stock valued at $53,000 after purchasing an additional 81 shares in the last quarter. 96.19% of the stock is currently owned by institutional investors.

About Itron

(Get Free Report)

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.

Read More

Analyst Recommendations for Itron (NASDAQ:ITRI)

Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.